To the full analysis
Buyback calculator for Nanobiotix
Nanobiotix stock: key metrics
NANO.PANanobiotix had an operating margin of −36.5% and a return on invested capital (ROIC) of −67% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2011 | 100.0% | −384.3% | −385.7% |
| 2012 | 100.0% | −6,948.9% | −7,189.0% |
| 2013 | 100.0% | −4,422.8% | −4,404.1% |
| 2014 | 100.0% | −347.2% | −344.9% |
| 2015 | 91.0% | −426.9% | −423.5% |
| 2016 | 92.0% | −403.1% | −403.6% |
| 2017 | 90.7% | −678.8% | −702.4% |
| 2018 | 100.0% | −864.2% | −872.2% |
| 2019 | 3,736.8% | −72,341.2% | −74,875.0% |
| 2020 | 4,650.0% | −72,856.0% | −67,180.0% |
| 2021 | 26,470.0% | −525,790.0% | −470,030.0% |
| 2022 | 68.6% | −1,057.2% | −1,194.3% |
| 2023 | 100.0% | −89.1% | −132.1% |
| 2024 | no data | no data | no data |
| 2025 | 100.0% | −36.5% | −80.8% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2011 | −100.0% | no data | −100.0% |
| 2012 | −49.8% | −58.1% | −38.0% |
| 2013 | −100.0% | −77.8% | −100.0% |
| 2014 | −31.5% | −40.7% | −25.8% |
| 2015 | −100.0% | −50.8% | −64.4% |
| 2016 | −100.0% | −79.1% | −72.0% |
| 2017 | −59.5% | −55.5% | −45.5% |
| 2018 | −100.0% | −56.7% | −65.7% |
| 2019 | 200.0% | no data | −90.8% |
| 2020 | −47.7% | −35.8% | −25.1% |
| 2021 | −100.0% | −43.6% | −46.2% |
| 2022 | 200.0% | −82.0% | −95.4% |
| 2023 | 200.0% | −57.7% | −42.3% |
| 2024 | 103.7% | no data | −100.0% |
| 2025 | 28.4% | −67.0% | −35.4% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 31 Oct 2013)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.